393 related articles for article (PubMed ID: 24836575)
1. Neutrophil granulocytes recruited upon translocation of intestinal bacteria enhance graft-versus-host disease via tissue damage.
Schwab L; Goroncy L; Palaniyandi S; Gautam S; Triantafyllopoulou A; Mocsai A; Reichardt W; Karlsson FJ; Radhakrishnan SV; Hanke K; Schmitt-Graeff A; Freudenberg M; von Loewenich FD; Wolf P; Leonhardt F; Baxan N; Pfeifer D; Schmah O; Schönle A; Martin SF; Mertelsmann R; Duyster J; Finke J; Prinz M; Henneke P; Häcker H; Hildebrandt GC; Häcker G; Zeiser R
Nat Med; 2014 Jun; 20(6):648-54. PubMed ID: 24836575
[TBL] [Abstract][Full Text] [Related]
2. Neutrophils provide cellular communication between ileum and mesenteric lymph nodes at graft-versus-host disease onset.
Hülsdünker J; Ottmüller KJ; Neeff HP; Koyama M; Gao Z; Thomas OS; Follo M; Al-Ahmad A; Prinz G; Duquesne S; Dierbach H; Kirschnek S; Lämmermann T; Blaser MJ; Fife BT; Blazar BR; Beilhack A; Hill GR; Häcker G; Zeiser R
Blood; 2018 Apr; 131(16):1858-1869. PubMed ID: 29463561
[TBL] [Abstract][Full Text] [Related]
3. TNFAIP8 Deficiency Exacerbates Acute Graft Versus Host Disease in a Murine Model of Allogeneic Hematopoietic Cell Transplantation.
Kumari R; Palaniyandi S; Strattan E; Huang T; Kohler K; Jabbour N; Dalland J; Du J; Kesler MV; Chen YH; Hildebrandt GC
Transplantation; 2020 Mar; 104(3):500-510. PubMed ID: 31634333
[TBL] [Abstract][Full Text] [Related]
4. Immunization against poly-
Hülsdünker J; Thomas OS; Haring E; Unger S; Gonzalo Núñez N; Tugues S; Gao Z; Duquesne S; Cywes-Bentley C; Oyardi O; Kirschnek S; Schmitt-Graeff A; Pabst O; Koenecke C; Duyster J; Apostolova P; Blaser MJ; Becher B; Pier GB; Häcker G; Zeiser R
Proc Natl Acad Sci U S A; 2019 Oct; 116(41):20700-20706. PubMed ID: 31527267
[TBL] [Abstract][Full Text] [Related]
5. Treatment with Apocynin Limits the Development of Acute Graft-versus-Host Disease in Mice.
Rezende BM; Bernardes PTT; Gonçalves WA; de Resende CB; Athayde RM; Ávila TV; Martins DG; Castor MGM; Teixeira MM; Pinho V
J Immunol Res; 2019; 2019():9015292. PubMed ID: 31781685
[TBL] [Abstract][Full Text] [Related]
6. Microbiome: An Emerging New Frontier in Graft-Versus-Host Disease.
Kumari R; Palaniyandi S; Hildebrandt GC
Dig Dis Sci; 2019 Mar; 64(3):669-677. PubMed ID: 30523482
[TBL] [Abstract][Full Text] [Related]
7. A Novel Function for P2Y2 in Myeloid Recipient-Derived Cells during Graft-versus-Host Disease.
Klämbt V; Wohlfeil SA; Schwab L; Hülsdünker J; Ayata K; Apostolova P; Schmitt-Graeff A; Dierbach H; Prinz G; Follo M; Prinz M; Idzko M; Zeiser R
J Immunol; 2015 Dec; 195(12):5795-804. PubMed ID: 26538394
[TBL] [Abstract][Full Text] [Related]
8. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
9. A single strain of Bacteroides fragilis protects gut integrity and reduces GVHD.
Sofi MH; Wu Y; Ticer T; Schutt S; Bastian D; Choi HJ; Tian L; Mealer C; Liu C; Westwater C; Armeson KE; Alekseyenko AV; Yu XZ
JCI Insight; 2021 Feb; 6(3):. PubMed ID: 33554953
[TBL] [Abstract][Full Text] [Related]
10. The Prolyl Hydroxylase Inhibitor Dimethyl Oxalyl Glycine Decreases Early Gastrointestinal GVHD in Experimental Allogeneic Hematopoietic Cell Transplantation.
Palaniyandi S; Kumari R; Venniyil Radhakrishnan S; Strattan E; Hakim N; Munker R; Kesler MV; Hildebrandt GC
Transplantation; 2020 Dec; 104(12):2507-2515. PubMed ID: 32639407
[TBL] [Abstract][Full Text] [Related]
11. TLR4 inactivation protects from graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Zhao Y; Liu Q; Yang L; He D; Wang L; Tian J; Li Y; Zi F; Bao H; Yang Y; Zheng Y; Shi J; Xue X; Cai Z
Cell Mol Immunol; 2013 Mar; 10(2):165-75. PubMed ID: 23262974
[TBL] [Abstract][Full Text] [Related]
12. Protective role of T-bet and Th1 cytokines in pulmonary graft-versus-host disease and peribronchiolar fibrosis.
Gowdy KM; Nugent JL; Martinu T; Potts E; Snyder LD; Foster WM; Palmer SM
Am J Respir Cell Mol Biol; 2012 Feb; 46(2):249-56. PubMed ID: 21960548
[TBL] [Abstract][Full Text] [Related]
13. Stool Microbiota at Neutrophil Recovery Is Predictive for Severe Acute Graft vs Host Disease After Hematopoietic Cell Transplantation.
Golob JL; Pergam SA; Srinivasan S; Fiedler TL; Liu C; Garcia K; Mielcarek M; Ko D; Aker S; Marquis S; Loeffelholz T; Plantinga A; Wu MC; Celustka K; Morrison A; Woodfield M; Fredricks DN
Clin Infect Dis; 2017 Nov; 65(12):1984-1991. PubMed ID: 29020185
[TBL] [Abstract][Full Text] [Related]
14. Reduced-Intensity Conditioning with Busulfan, Fludarabine, and Antithymocyte Globulin for Hematopoietic Cell Transplantation from Unrelated or Haploidentical Family Donors in Patients with Acute Myeloid Leukemia in Remission.
Lee KH; Lee JH; Lee JH; Kim DY; Park HS; Choi EJ; Ko SH; Seol M; Lee YS; Kang YA; Jeon M; Baek S; Kang YL; Kim SH; Yun SC; Kim H; Jo JC; Choi Y; Joo YD; Lim SN
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1555-1566. PubMed ID: 28552421
[TBL] [Abstract][Full Text] [Related]
15. Blockade of TIM-1 on the donor graft ameliorates graft-versus-host disease following hematopoietic cell transplantation.
Iliopoulou BP; Hsu K; Pérez-Cruz M; Tang SW; Pang WW; Erkers T; Kambham N; Freeman GJ; Dekruyff RH; Meyer EH
Blood Adv; 2019 Nov; 3(21):3419-3431. PubMed ID: 31714958
[TBL] [Abstract][Full Text] [Related]
16. Neutrophils: bugging transplantation.
Kugelberg E
Nat Rev Immunol; 2014 Jul; 14(7):430-1. PubMed ID: 24903912
[No Abstract] [Full Text] [Related]
17. Glucagon-like peptide 2 for intestinal stem cell and Paneth cell repair during graft-versus-host disease in mice and humans.
Norona J; Apostolova P; Schmidt D; Ihlemann R; Reischmann N; Taylor G; Köhler N; de Heer J; Heeg S; Andrieux G; Siranosian BA; Schmitt-Graeff A; Pfeifer D; Catalano A; Frew IJ; Proietti M; Grimbacher B; Bulashevska A; Bhatt AS; Brummer T; Clauditz T; Zabelina T; Kroeger N; Blazar BR; Boerries M; Ayuk F; Zeiser R
Blood; 2020 Sep; 136(12):1442-1455. PubMed ID: 32542357
[TBL] [Abstract][Full Text] [Related]
18. Pretransplant CSF-1 therapy expands recipient macrophages and ameliorates GVHD after allogeneic hematopoietic cell transplantation.
Hashimoto D; Chow A; Greter M; Saenger Y; Kwan WH; Leboeuf M; Ginhoux F; Ochando JC; Kunisaki Y; van Rooijen N; Liu C; Teshima T; Heeger PS; Stanley ER; Frenette PS; Merad M
J Exp Med; 2011 May; 208(5):1069-82. PubMed ID: 21536742
[TBL] [Abstract][Full Text] [Related]
19. TAK1 inhibition ameliorates survival from graft-versus-host disease in an allogeneic murine marrow transplantation model.
Kobayashi A; Kobayashi S; Miyai K; Osawa Y; Horiuchi T; Kato S; Maekawa T; Yamamura T; Watanabe J; Sato K; Tsuda H; Kimura F
Int J Hematol; 2018 Feb; 107(2):222-229. PubMed ID: 29027124
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial Deacetylase SIRT3 Plays an Important Role in Donor T Cell Responses after Experimental Allogeneic Hematopoietic Transplantation.
Toubai T; Tamaki H; Peltier DC; Rossi C; Oravecz-Wilson K; Liu C; Zajac C; Wu J; Sun Y; Fujiwara H; Henig I; Kim S; Lombard DB; Reddy P
J Immunol; 2018 Dec; 201(11):3443-3455. PubMed ID: 30389773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
